Ex Parte STEINEMANN et al - Page 4




             Appeal No. 2001-1685                                                                                     
             Application No. 08/596,698                                                                               
             expectation of success to one reasonably skilled in the art.  In re Vaeck, 947 F.2d 488,                 
             493, 20 USPQ2d 1438, 1442 (Fed. Cir. 1991).                                                              
                    Iverson addresses the same problem as that of the claimed invention, the                          
             treatment and prevention of fibrin formation in the eye, such as after surgery, by                       
             administration of heparin, an anticoagulant.   Bang teaches the general administration of                
             protein C systemically to reduce vascular fibrin formation, but does not teach                           
             administration of protein C systemically or otherwise to treat the eye.                                  
                    It is the examiner=s position that (Answer, page 4):                                              
                           Iverson teaches that the intraocular fibrin formation during                               
                    Vitrectomy is inhibited by heparin (note the abstract and page 405).   Iverson                    
                    does not specifically teach the use of protein C. ....                                            
                           The use of protein C to reduce the fibrin formation or the treatment                       
                    of a disease resulting from such fibrin formation, instead of heparin taught                      
                    by Iverson would have been obvious to an artisan since Bang teaches its                           
                    superiority over heparin taught by Bang.                                                          
                           Put in another way:   Iverson teaches that intraocular fibrin is the                       
                    result of blood coagulation and can be reduced in an individual by                                
                    administering heparin as the anticoagulant.                                                       
                           Bang teaches that protein C is a better anticoagulant than heparin.                        
                    Therefore, it would be prima facie obvious to substitute protein C for the                        
                    heparin of Iverson as an anticoagulant with a reasonable expectation of                           
                    success that it too would reduce intraocular fibrin formation.                                    
                    Appellants argue that “a person of ordinary skill in the art would not have had a                 
             reasonable expectation that protein C would have a pharmacological effect in the eye.”                   
             Brief, page 6.   In support of this position appellants argue that “delivery of therapeutic              
             pharmaceuticals to the eye is not a trivial matter.   In many instances, systemically                    
             administered drugs do not reach the eye in therapeutic levels; and ... [m]any drugs, if                  


                                                          4                                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007